Neuromodulation Devices Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Electrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has property to activate electrical impulse and transmit signal to electrodes of device, which causes depolarization and in turn reduces pain and improves muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.

Restraints of the Global Neuromodulation Devices Market

Side effects and risks associated with the use of neuromodulation devices are expected to hinder growth of the global neuromodulation devices market.

Key features of the study:

• This report provides in-depth analysis of the global neuromodulation devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global neuromodulation devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Axonics Modulation Technologies, Inc., ShiraTronics, Inc., Bioness, Inc., LivaNova, Neuronetics, Inc., Medtronic plc, St. Jude Medical, Boston Scientific Corporation, Cyberonics, Nevro, Integer Holdings Corporation, and Uroplasty
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Neuromodulation Devices Market, By Device Type:

• Spinal Cord Stimulation Devices
• Deep Brain Stimulation Devices
• Sacral Nerve Stimulation Devices
• Vagus Nerve Stimulation Devices
• Gastric Electric Stimulation Devices

Global Neuromodulation Devices Market, By Application:

• Pain Management
• Neurological and Movement Disorder Management
• Musculoskeletal Disorder Management
• Metabolism & GIT Management
• Incontinence Management
• Others

Global Neuromodulation Devices Market, By End User:

• Hospitals
• Specialty Clinics
• Ambulatory Centers
• Others

Global Neuromodulation Devices Market, By Geography:

• North America

o By Country:

• U.S.
• Canada
• Europe

o By Country:

• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific

o By Country:

• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America

o By Country:

• Brazil
• Mexico
• Argentina
• Rest of Latin America

o Middle East:

o By Country:

• GCC
• Israel
• Rest of Middle East
• Africa

o By Country/Region:

• Central Africa
• South Africa
• North Africa
• Company Profiles
• Axonics Modulation Technologies, Inc.*
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
• ShiraTronics, Inc.
• Bioness, Inc.
• LivaNova
• Neuronetics, Inc.
• Medtronic plc
• St. Jude Medical
• Boston Scientific Corporation
• Cyberonics
• Nevro
• Integer Holdings Corporation
• Uroplasty

“*” marked represents similar segmentation in other categories in the respective section.